Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex

Ryan Smith, Kewei Chen, Leslie Baxter, Carolyn Fort, Richard D Lane

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Structural brain imaging has revealed differences in gray matter volume between depressed individuals and control subjects in key structures related to emotion. The aim of the present study was to assess within subjects whether regional changes in gray matter volume were observed over time in depressed patients treated with sertraline. Methods: Thirteen depressed patients were assigned to selective serotonin reuptake inhibitor (SSRI) treatment with sertraline. Structural magnetic resonance imaging (MRI) was performed at four time points over 12 weeks of treatment. Depressed individuals were compared to a control group of 10 subjects scanned at the same time points using voxel based morphometry and a statistical growth modeling technique. Results: SSRI-treated patients showed a region of significantly increasing gray matter volume over time within the left dorsolateral prefrontal cortex (DLPFC) that specifically correlated with decreases in self-reported depression levels. No statistically significant changes were observed related to time in controls. Limitations: This study included a small sample size and the method of analysis was capable of detecting only linear changes in volume. Conclusions: Effective antidepressant treatment with sertraline is associated with left DLPFC volume increases. These volume increases may reflect cortical architectural changes associated with top-down neuronal modulation of emotion.

Original languageEnglish (US)
Pages (from-to)414-419
Number of pages6
JournalJournal of Affective Disorders
Volume146
Issue number3
DOIs
StatePublished - Apr 25 2013

Fingerprint

Sertraline
Prefrontal Cortex
Antidepressive Agents
Serotonin Uptake Inhibitors
Emotions
Neuroimaging
Sample Size
Therapeutics
Magnetic Resonance Imaging
Depression
Control Groups
Growth
Gray Matter

Keywords

  • Longitudinal
  • Major depression
  • MRI
  • SSRI
  • Voxel-based morphometry (VBM)

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex. / Smith, Ryan; Chen, Kewei; Baxter, Leslie; Fort, Carolyn; Lane, Richard D.

In: Journal of Affective Disorders, Vol. 146, No. 3, 25.04.2013, p. 414-419.

Research output: Contribution to journalArticle

Smith, Ryan ; Chen, Kewei ; Baxter, Leslie ; Fort, Carolyn ; Lane, Richard D. / Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex. In: Journal of Affective Disorders. 2013 ; Vol. 146, No. 3. pp. 414-419.
@article{67a545870dd743adaa5027ba97c84219,
title = "Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex",
abstract = "Background: Structural brain imaging has revealed differences in gray matter volume between depressed individuals and control subjects in key structures related to emotion. The aim of the present study was to assess within subjects whether regional changes in gray matter volume were observed over time in depressed patients treated with sertraline. Methods: Thirteen depressed patients were assigned to selective serotonin reuptake inhibitor (SSRI) treatment with sertraline. Structural magnetic resonance imaging (MRI) was performed at four time points over 12 weeks of treatment. Depressed individuals were compared to a control group of 10 subjects scanned at the same time points using voxel based morphometry and a statistical growth modeling technique. Results: SSRI-treated patients showed a region of significantly increasing gray matter volume over time within the left dorsolateral prefrontal cortex (DLPFC) that specifically correlated with decreases in self-reported depression levels. No statistically significant changes were observed related to time in controls. Limitations: This study included a small sample size and the method of analysis was capable of detecting only linear changes in volume. Conclusions: Effective antidepressant treatment with sertraline is associated with left DLPFC volume increases. These volume increases may reflect cortical architectural changes associated with top-down neuronal modulation of emotion.",
keywords = "Longitudinal, Major depression, MRI, SSRI, Voxel-based morphometry (VBM)",
author = "Ryan Smith and Kewei Chen and Leslie Baxter and Carolyn Fort and Lane, {Richard D}",
year = "2013",
month = "4",
day = "25",
doi = "10.1016/j.jad.2012.07.029",
language = "English (US)",
volume = "146",
pages = "414--419",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex

AU - Smith, Ryan

AU - Chen, Kewei

AU - Baxter, Leslie

AU - Fort, Carolyn

AU - Lane, Richard D

PY - 2013/4/25

Y1 - 2013/4/25

N2 - Background: Structural brain imaging has revealed differences in gray matter volume between depressed individuals and control subjects in key structures related to emotion. The aim of the present study was to assess within subjects whether regional changes in gray matter volume were observed over time in depressed patients treated with sertraline. Methods: Thirteen depressed patients were assigned to selective serotonin reuptake inhibitor (SSRI) treatment with sertraline. Structural magnetic resonance imaging (MRI) was performed at four time points over 12 weeks of treatment. Depressed individuals were compared to a control group of 10 subjects scanned at the same time points using voxel based morphometry and a statistical growth modeling technique. Results: SSRI-treated patients showed a region of significantly increasing gray matter volume over time within the left dorsolateral prefrontal cortex (DLPFC) that specifically correlated with decreases in self-reported depression levels. No statistically significant changes were observed related to time in controls. Limitations: This study included a small sample size and the method of analysis was capable of detecting only linear changes in volume. Conclusions: Effective antidepressant treatment with sertraline is associated with left DLPFC volume increases. These volume increases may reflect cortical architectural changes associated with top-down neuronal modulation of emotion.

AB - Background: Structural brain imaging has revealed differences in gray matter volume between depressed individuals and control subjects in key structures related to emotion. The aim of the present study was to assess within subjects whether regional changes in gray matter volume were observed over time in depressed patients treated with sertraline. Methods: Thirteen depressed patients were assigned to selective serotonin reuptake inhibitor (SSRI) treatment with sertraline. Structural magnetic resonance imaging (MRI) was performed at four time points over 12 weeks of treatment. Depressed individuals were compared to a control group of 10 subjects scanned at the same time points using voxel based morphometry and a statistical growth modeling technique. Results: SSRI-treated patients showed a region of significantly increasing gray matter volume over time within the left dorsolateral prefrontal cortex (DLPFC) that specifically correlated with decreases in self-reported depression levels. No statistically significant changes were observed related to time in controls. Limitations: This study included a small sample size and the method of analysis was capable of detecting only linear changes in volume. Conclusions: Effective antidepressant treatment with sertraline is associated with left DLPFC volume increases. These volume increases may reflect cortical architectural changes associated with top-down neuronal modulation of emotion.

KW - Longitudinal

KW - Major depression

KW - MRI

KW - SSRI

KW - Voxel-based morphometry (VBM)

UR - http://www.scopus.com/inward/record.url?scp=84875226461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875226461&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2012.07.029

DO - 10.1016/j.jad.2012.07.029

M3 - Article

C2 - 23017544

AN - SCOPUS:84875226461

VL - 146

SP - 414

EP - 419

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

IS - 3

ER -